Healthcare booking platform Practo, and taxi-hailing platform Uber has announced a global partnership to help people reach doctors easily. Across India, Indonesia, Philippines and Singapore, those who book an appointment on Practo’s mobile application will be able to view the closest Uber available along with the appointment reminder alert. The next phase of integration will involve notifying the user to request for an Uber, an hour prior to the appointment.
Piramal Healthcare has invested two million pounds (about Rs 20 crore) to expand its manufacturing plant in Scotland. The plant manufactures anti-cancer drugs (antibody drug conjugates) for export. This new investment into Scotland will yield additional revenue of 3-5 million pounds (about Rs 30-50 crore) over five years to Piramal Healthcare’s revenue. Piramal Healthcare has manufacturing plants in India, US, Canada and Scotland and contributes to about 60% of the Rs 5,000 crore group revenue in FY15.
Practo, Asia’s largest online healthcare platform, is set to launch a wellness unit for bookings at spas and salons. Medical app Lybrate sees most users on its platform engaged in discussions on wellness than on other health topics. Unlike with doctor appointments, people need (beauty and wellness) services on a monthly basis.
Booking appointments with doctors is mostly a one-off activity, and yet to be monetised by health-tech firms, which make money primarily from selling appointment management software to doctors. In the wellness space, these firms are able to negotiate a commission for bringing in customers to salons and spas, making for a steady revenue stream and putting them in competition with home service companies. The value that technology firms such as Ziffi and Bookmyspa offer salons and spas is a chance to lower costs, as these establishments otherwise spends a significant chunk of their revenue on promotions.
Dr Reddy’s has completed the purchase of worldwide exclusive Intellectual Property Rights (IPR) for Fondaparinux sodium, its generic anti-coagulant drug, from Australian partner Alchemia for $17.5 million (around Rs 115 crore). Fondaparinux is a generic version of the anticoagulant drug Arixtra, which is approved in the US and Europe for the treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE).
Zigy, an online marketplace connecting chemists with consumers, has partnered with Lifespan, the world’s largest chain of diabetes management clinics, to help make diabetes care more accessible and affordable in India. As part of the tie-up, Lifespan products will be made available on Zigy in Mumbai, Delhi, Bengaluru, Chennai and Hyderabad